Oct 13, 2021 08:00AM

Apr 15, 2021 04:52PM

Mar 24, 2021 08:00AM

Jan 6, 2021 08:31AM

Jan 6, 2021 08:30AM

Jan 10, 2020 05:00PM

Aug 9, 2019 08:00AM Gemphire Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Jul 24, 2019 04:03PM

Jul 24, 2019 04:01PM

Jun 26, 2019 08:03AM

Jun 26, 2019 08:00AM

Mar 15, 2019 08:00AM

Dec 3, 2018 08:06AM

Dec 3, 2018 08:00AM Gemphire Therapeutics Announces Review of Strategic Alternatives and Provides Corporate Update

Nov 8, 2018 04:01PM

Sep 24, 2018 05:07PM

Sep 24, 2018 05:06PM

Aug 13, 2018 04:01PM

Aug 7, 2018 09:20AM

Aug 6, 2018 06:10PM

Aug 6, 2018 04:04PM Gemphire Therapeutics (GEMP) Says FDA has Requested Data from Sub-chronic Toxicology Study to provide Information to support Lifting Partial Clinical hold on Gemcabene

Aug 6, 2018 04:01PM

Jun 29, 2018 09:26AM

Jun 28, 2018 04:02PM

Jun 28, 2018 04:01PM

May 8, 2018 04:01PM

Mar 15, 2018 04:01PM

Jan 31, 2018 04:01PM Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD)

Dec 21, 2017 06:03AM

Dec 21, 2017 06:00AM

Nov 13, 2017 01:30PM

Nov 2, 2017 07:00AM

Oct 23, 2017 08:05AM

Oct 23, 2017 08:00AM

Sep 25, 2017 09:00AM Gemphire to Present New COBALT-1 Clinical Data at the 2017 FH Global Summit

Sep 20, 2017 09:29AM

Sep 19, 2017 06:17PM

Sep 19, 2017 04:02PM

Sep 19, 2017 04:01PM

Aug 7, 2017 09:33AM

Jun 28, 2017 04:02PM

Jun 28, 2017 04:01PM Gemphire Announces Top-Line Data from COBALT-1 Phase 2b Clinical Trial in HoFH Patients

May 31, 2017 09:26AM

Mar 15, 2017 04:01PM

Jan 30, 2017 06:06AM

Jan 30, 2017 06:00AM

Jan 9, 2017 08:00AM

325,058 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All